Irish flag as shield

Female breast cancer trends: Ireland

Female breast cancer trends – Ireland National Cancer Registry report shows 1 in 10 women in Ireland will develop malignant breast cancer before her 75th birthday.  Breast cancer is the commonest malignant tumour diagnosed in Irish women, with 2,883 cases diagnosed each year on average during 2011-2013, almost one third of  major malignancies diagnosed in…

Read More

A strong National Emission Ceiling (NEC) Directive

An Open letter To:  EU Ministers for a strong National Emission Ceiling (NEC) Directive Dear Ministers, Subject: Public Health recommendations for strong National Emission Ceiling (NEC) Directive We, the undersigned 17 health organisations, representing thousands of health professionals and affected European citizens, are writing to you ahead of the 16th December meeting where you will…

Read More

e-learning about Angiogenesis in Gastric Cancer

Stomach cancer, also known as gastric cancer is the third most common cause of cancer-related death in the world, and it remains difficult to cure in Western countries, mainly as most patients present with advanced disease. To understand more about angiogenesis in gastric cancer, cancer.org have produced informaiton sets including: Angiogenesis in Gastric Cancer e-learning module…

Read More

.scot: Health boards to reduce cancer waiting times

Health boards to reduce cancer waiting times Health boards share over £4 million to reduce cancer waiting times after performance target drop and will help improve on diagnostic wait across country and provide local support. In the first quarter of 2015, 91.8 per cent of patients urgently referred with suspicion of cancer began treatment within…

Read More

Uk: Cancer kills more men than other diseases

Cancer kills more men than other diseases in UK Now primary cause of death since 1960 Male deaths from cancer 29% Male cardiovascular disease 28% Heart disease remains most common cause of death amongst women. Cancer has now overtaken heart disease as the biggest killer of British men, research says, but heart disease is still…

Read More

UK: Treatment guides for treating kidney and prostate cancer

Final guidance on use of axitinib for treating kidney cancer and sipuleucel-T for prostate cancer. Guidance issued to the NHS today, recommends that the drug axitinib, known as Inlyta by Pfizer, should be available as a second line treatment for kidney cancer. A separate new guide did not recommended sipuleucel-T, known as Provenge, for treating…

Read More

UK: Guidance on pomalidomide for blood cancer

Final draft guidance on pomalidomide for blood cancer Not recommending pomalidomide, also known as Imnovid, for treating multiple myeloma. Multiple myeloma is a cancer that affects plasma cells, i.e. white blood cell found in bone marrow. Although incurable, there are a number of treatments that help slow the disease progress and improve quality of life. …

Read More
European Institute of womens health, Eurohealth health logo

European Cervical Cancer Week, 2015

Press release The European Institute of Women’s Health (EIWH) supports European Cervical Cancer Week Jan 25-31st 2015 The prevention of cervical cancer has the potential to become a major public health success  story. We should be able to lower rates of cervical cancer even further, if best practice in early detection through cancer screening and…

Read More

Prostate cancer treatment too expensive!

Sipuleucel-T cost too high for prostate cancer patients Final draft guidance not recommending sipuleucel-T for use with: Prostate cancer in men whose disease has spread, Who have few symptoms and with disease not yet suitable for chemotherapy treatment. Evidence showed price to NHS too high for potential benefit it may provide to patients. Sipuleucel-T, known…

Read More